These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Comparison of Sebia Capillarys Flex capillary electrophoresis with the BioRad Variant II high pressure liquid chromatography in the evaluation of hemoglobinopathies.
    Author: Greene DN, Pyle AL, Chang JS, Hoke C, Lorey T.
    Journal: Clin Chim Acta; 2012 Aug 16; 413(15-16):1232-8. PubMed ID: 22515960.
    Abstract:
    BACKGROUND: There are multiple biochemical screening techniques for assessing hemoglobinopathies. Here we compare a new instrument, the Sebia Capillarys Flex (capillary zone electrophoresis (CE)), with the BioRad Variant II (high pressure liquid chromatography (HPLC) in the evaluation of hemoglobinopathies. METHODS: This was a retrospective study using 174 whole blood samples encompassing the 5 most common (Hb A, A2', S, C, and E) and 10 rare (Hb G(Philidelphia), D, H, Bart's, O(Arab), S/G(Philidelphia), Hasharoon, Q(India), N(Baltimore), and Malmo) hemoglobin variants. An additional 126 samples were used to establish a CE reference interval for Hb A2. RESULTS: Hb A measurements agreed well between the 2 methods (bias=-0.06;r=0.999). The agreement of Hb F was also very good (bias=-0.17; r=0.994). When samples with the highest Hb F concentration were excluded, agreement was less precise (bias=-0.44; r=0.811). When no variant was present, the Hb A2 concentrations showed excellent agreement (bias=0.00; r=0.994). Positive bias for Hb A2 is seen when Hb C is present using CE. The Hb A2 reference interval using CE was <3.2%. CONCLUSION: The Capillarys Flex is capable of identifying and quantifying hemoglobin species, consistent with existing HPLC methods.
    [Abstract] [Full Text] [Related] [New Search]